BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ahluwalia M, Bangalore S. Management of hypertension in 2017: targets and therapies. Current Opinion in Cardiology 2017;32:413-21. [DOI: 10.1097/hco.0000000000000408] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Para I, Albu A, Porojan MD. Adipokines and Arterial Stiffness in Obesity. Medicina (Kaunas) 2021;57:653. [PMID: 34202323 DOI: 10.3390/medicina57070653] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
2 Ogundele S, Ajibare A, Amisu M, Dada A. Prescription pattern and blood pressure control among patients on antihypertensive medications attending a tertiary hospital in Lagos: A cross-sectional study. Niger J Basic Clin Sci 2021;18:9. [DOI: 10.4103/njbcs.njbcs_12_20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Zhang JR, Sun HJ. Extracellular Vesicle-Mediated Vascular Cell Communications in Hypertension: Mechanism Insights and Therapeutic Potential of ncRNAs. Cardiovasc Drugs Ther 2020. [PMID: 32964302 DOI: 10.1007/s10557-020-07080-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
4 Aggile K, Alagumuthu M, Kumar P, Napoleon AA. Improved multicomponent, one‐pot synthesis of functionalized tetrahydropyrans cardiovascular dysfunction regulators. J Heterocyclic Chem 2020;57:1403-1413. [DOI: 10.1002/jhet.3876] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
5 Li X, Chang P, Wang Q, Hu H, Bai F, Li N, Yu J. Effects of Angiotensin-Converting Enzyme Inhibitors on Arterial Stiffness: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Cardiovasc Ther 2020;2020:7056184. [PMID: 32190121 DOI: 10.1155/2020/7056184] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
6 Wu D, Ding L, Tang X, Wang W, Chen Y, Zhang T. Baicalin Protects Against Hypertension-Associated Intestinal Barrier Impairment in Part Through Enhanced Microbial Production of Short-Chain Fatty Acids. Front Pharmacol 2019;10:1271. [PMID: 31719823 DOI: 10.3389/fphar.2019.01271] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
7 Joel CH, Sutopo CCY, Prajitno A, Su JH, Hsu JL. Screening of Angiotensin-I Converting Enzyme Inhibitory Peptides Derived from Caulerpa lentillifera. Molecules 2018;23:E3005. [PMID: 30453595 DOI: 10.3390/molecules23113005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
8 Howell SJ. Preoperative Hypertension. Curr Anesthesiol Rep 2018;8:25-31. [PMID: 29527133 DOI: 10.1007/s40140-018-0248-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
9 Lee D, Jo EJ, Ga E, Han J, Jung S, Park H, Heo K, Myung C. Effects of combination therapy with candesartan and ramipril on hypertension and related complications. Journal of Pharmaceutical Investigation 2017;47:365-71. [DOI: 10.1007/s40005-017-0339-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]